Lisa Ricciardi, president and CEO of Cognition Therapeutics (NASDAQ: CGTX) was recently a guest on Benzinga’s All-Access. Cognition Therapeutics is a neuroscience company that is developing oral ...

Cognition Therapeutics is a neuroscience company that is developing oral medications to treat neurodegenerative disorders, with recent breakthroughs in the treatment of dementia with Lewy bodies ...

In assessing the role of pharmacists in prescribing and transcribing, the present study sought to describe pharmacy and therapeutics (P&T) committee activities, the process of formulary system ...

This exception could provide certain tax advantages for investors dealing in Prime US REIT’s publicly traded partnership transfers over a 90-day period. For further insights into SG:OXMU stock ...

The rebel group Hayat Tahrir al-Sham has established an interim government with a new prime minister, aiming to rebuild Syria’s war-torn economy after over a decade of civil war.

Chroma Medicine and Nvelop Therapeutics merge to bring together ... other top tier investors including 5AM Ventures, DCVC Bio, F-Prime Capital, GV (Google Ventures), Janus Henderson Investors ...

The inclusion of Livongo on the formulary is hardly a surprise, though - it has been partnered with Express Scripts since October 2015 with its diabetes service.